chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient complained of arm soreness, slight fever (100 degrees), increase heart rate and confusion. Stated he felt like he could "see beating in his head" when he describe how he felt confused.
can you get side effects next day; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (can you get side effects next day) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (can you get side effects next day). At the time of the report, VACCINATION COMPLICATION (can you get side effects next day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  No treatment medication was reported.
Within 3 hours of shot developed a large ball upper left arm and a red rash that spread throughout upper arm. Had a low grade fever, diarrhea loss of appetite for 4 days. On the 8th day the rash returned and had severe vomiting, fever, chills, loss of energy that lasted 6 days
This spontaneous report was received from a licensed practical nurse and refers to an unspecified number of patients of unknown age and gender. No information about the patients' pertinent medical history, concomitant medications and drug reactions or allergies were reported. On an unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 injection, lot # M026306, expiry date 30-APR-2018 (dose, route of administration and anatomical location were not specified). The administered doses of GARDASIL 9 underwent temperature excursion under 13.3 Fahrenheit degrees for 7.5 hours in the freezer and 62.6 Fahrenheit degrees for 10 hours in the refrigerator. No prior excursions were reported. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Chills, shivering, low temperature (95° F), vomiting followed by fever (101° F)
feels slight numbness; tingling in lower-left jaw; muscle pain in upper neck and shoulders coming from spine days later; This is a spontaneous report from contactable consumer via Pfizer Sales Representative. The consumer reported for himself that:  A male patient of unspecified age (38-Unit Unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8733), via an unspecified route of administration, administered in Arm Left on an unspecified date as DOSE 1 SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took cortisone. (Patient had received a cortisone injection in his left arm's elbow one month prior to getting this vaccine in the same (left) arm.). On an unspecified date, 4 hours after first COVID vaccine shot, the patient had left-hand side of face (primarily lower-left jaw) and upper neck muscles felt tingling and as if they were going numb. Sensation grew more extreme for 15 minutes, then diminished. Less-extreme recurrence of said symptoms happened twice several days later, both for a half an hour long. Still feels slight numbness and tingling in lower-left jaw, even more days later and reported muscle pain in upper neck and shoulders coming from spine days later. At the time of this report event outcome was unknown.  No follow up attempts are possible. No further information is expected.
called patient for follow-up on 5/13/21.  Patient reported feeling a little tired and having a slightly sore arm.  (Typical symptoms from a covid vaccine)......nothing reported out of the ordinary
This case was reported by a healthcare professional and described the occurrence of arm pain in a 59-year-old female subject who was vaccinated with FLULAVAL (GlaxoSmithKline). The subject's medical history included shoulder problems. Concurrent medical conditions included thyroid problems. Concurrent medications included Multivitamins and Levothyroxine. On 4 October 2010 at 10:00 the subject received a dose of FLULAVAL (.5 ml, unknown route, left deltoid). On 4 October 2010, 5 hours after vaccination with FLULAVAL, the subject experienced left arm pain that radiated to her fingers, joint pain that radiated to her hand, paresthesia, left arm numbness and tingling in her left arm. The healthcare professional considered that the events were a systemic reaction. The subject was treated with TYLENOL and MOTRIN. At the time of reporting the events were unresolved.
Pt was given 0.2 ml of the Pediatric formulation which means that she was under-dosed by more than 50%.
This spontaneous report was received from a healthcare worker and refers to an unspecified number of male patients over the age of 15 years. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories reported. On unknown dates, the patients were vaccinated with doses of GARDASIL 9 (dose, frequency, route of administration, lot # and expiration date were not reported). There were no adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sore, reddened hardness at injection site.  When returned to clinic site of injection 55m width.  Warm soaks three times a day, Ibuprofen every 6-8 hours, BENADRYL at ns. Follow up telephone call 08/23/2005 area no longer sore to touch, knot remains but smaller in size.  Reassure this is common reaction post Td.
Throat began tightening up. Used Albuterol and was given Benadryl and oxygen.
sore arm; fatigue for about a couple of days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue for about a couple of days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue for about a couple of days). At the time of the report, PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue for about a couple of days) outcome was unknown.            No treatment and concomitant medication information was reported.   This case was linked to MOD-2021-097892.   Most recent FOLLOW-UP information incorporated above includes: On 30-May-2021: Follow up received on 30-May-2021: includes no new information (NNI).
Fever, chills, achy, fatigue- began on 2/27/21 @1am Fever went as high as 101.3 degrees. Soreness on arm at injection site as well.
Body aches; Body chills; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP6955), via an unspecified route of administration in the left arm on 22Mar2021 at 09:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included kidney stones. Concomitant medication included levothyroxine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient previously received tramadol (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 27Mar2021 (reported as after 6 days), after receiving vaccine, the patient started experiencing body chills, headache and body aches. The patient still had chills off and on. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab test on 28Mar2021 which included nasal swab and the test result was negative. The patient did not receive any treatment for the events body chills, headache and body aches. The clinical outcome of the events chills, headache and general body pain were recovering at the time of the report.   No follow-up attempts are possible. No further information is expected.
Immediately developed pain, swelling and erythema in arm.  Next morning had severe diarrhea and came to physician office with orthostasis, pre-syncope and hypotension.  Supine pulse 96, BP 110/64.  Upright pulse 135, BP 88/60.
Fever 101. Body aches, chills, general malaise, no appetite, sore arm  for 2 and 1/2 days. Rested, po fluids, Tylenol. Stayed home from work 3 days.
Pt rec'd Dtap, Prevnar in Lt appears red, hot to touch and swollen. Mom states getting worse. Pt temp 97.3.
Menactra given 04/04/2007. Later that evening the patient devvelped a temp of 101, had nausea and felt lightheaded.  Left arm was red and swollen and he states that every muscle in his body hurt.  On 4/5/07 patient was seen by family physician.  Was given Rx of Keflex and continued on routine medications, Allegra and Singular.  Continued with lightheadedness and muscle aches until 4/8/07.  On 4/9/07 muscle aches did decrease.
redness in arm is still ongoing; swelling; soreness became worse.; In bed for a while.; had temperature; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness in arm is still ongoing), SWELLING (swelling), ARTHRALGIA (soreness became worse.), BED REST (In bed for a while.) and PYREXIA (had temperature) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00ZBZ1A) for COVID-19 vaccination.     No medical history was reported by the reporter.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced ERYTHEMA (redness in arm is still ongoing), SWELLING (swelling), ARTHRALGIA (soreness became worse.), BED REST (In bed for a while.) and PYREXIA (had temperature). At the time of the report, ERYTHEMA (redness in arm is still ongoing), SWELLING (swelling), ARTHRALGIA (soreness became worse.), BED REST (In bed for a while.) and PYREXIA (had temperature) had not resolved. Not Provided            Patient received treatment with ice.
pt recvd vax & was found to have elevated liver enzymes;MD will follow liver enzymes;
Deployed to Africa 10/14. Maxofacial surg/sleep apnea. 02/10-surg/symptoms dyspnea,awakening. Prev proc tonsilectomy,adenoectomy,UPPP,LAUP,bimaxillary advan,fractured max boneplates.Hyperlipidemia 3/12 & 3/16.wt gain,hand pain, systemic rxn
The child had seen his pediatric provider 2 days prior to presentation to emergency department and had immunizations. The day prior to presentation, the child was seen for loose stools. He was described as nontoxic in appearance and feeding okay with normal urinary output. Presented to the emergency department via ambulance with CPR in progress after suffering an in-home arrest.  Resuscitation was terminated after patient's arrival and patient was pronounced as deceased.
sore arm; Had itching in the past, resolved and after vaccine itching started again, all over body; Achiness, headaches, sore arm; Achiness, headaches, sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achiness, headaches, sore arm), PAIN IN EXTREMITY (sore arm), PRURITUS (Had itching in the past, resolved and after vaccine itching started again, all over body) and HEADACHE (Achiness, headaches, sore arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included FISH OIL, POTASSIUM, VITAMIN D3, ELDERBERRY [SAMBUCUS NIGRA] and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced PAIN (Achiness, headaches, sore arm). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), PRURITUS (Had itching in the past, resolved and after vaccine itching started again, all over body) and HEADACHE (Achiness, headaches, sore arm). At the time of the report, PAIN (Achiness, headaches, sore arm), PAIN IN EXTREMITY (sore arm), PRURITUS (Had itching in the past, resolved and after vaccine itching started again, all over body) and HEADACHE (Achiness, headaches, sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
a little tired; This is a spontaneous report received from a contactable consumer (patient). This male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization.  The patient medical history included shingles complications. Concomitant medication included pregabalin (LYRICA) taken for shingles complications. The patient reported receiving the first dose of the Pfizer covid-19 vaccine and not having any side effects other than feeling a little tired. The consumer reported he had been taking LYRICA for the past 2 months for treatment of shingles complications and his current dose was down to LYRICA 100 mg twice a day. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient is a 71-year-old female with history of hypertension, hyperlipidemia, and obesity who presents with complaint of acute onset shortness of breath.  She reports she was walking around her house earlier when she suddenly became short of breath.  She denies any chest pain, numbness or tingling but states that shortness of breath persisted.  She denies any tobacco, alcohol or drug use and states she has never had any symptoms similar to this before.  Denies any lung disease or heart disease previously.  She does have hypertension and hyperlipidemia and is on metoprolol and rosuvastatin respectively which she reports good compliance.  Denies family history of MI or strokes.  She also denies other symptoms such as nausea, vomiting, abdominal pain, fevers or lower extremity edema.  In the ED vitals were found to be within normal limits.  EKG was obtained showing diffuse T wave inversions, right bundle branch block, no ST changes, no hypertrophy.  Troponin found to be elevated at 0.137, creatinine elevated at 1.3, BUN 26.  Chest x-ray was within normal limits.  Otherwise lab work was unremarkable.  She was given aspirin and Nitropaste Hospital Course:         Patient was admitted to the medical floor and remained hemodynamically stable throughout her stay. She actually remained asymptomatic and had no further shortness of breath. She was not hypoxic, at no point required supplemental oxygen. Her troponins however continued to uptrend to 0.389. Cardiology consulted, she was medically optimized with increased statin dose, therapeutic lovenox, and aspirin. Original plan was for cardiac catheterization. However, a d-dimer was ordered which returned elevated to 13.7. CTA was performed which revealed extensive bilateral pulmonary emboli with large clot burden and concern for right heart strain. Echocardiogram showed mildly dilated and hypokinetic RV with mild diastolic dysfunction with impaired relaxation. She was deemed not to be candidate for EKOS. Troponin elevation was felt to be type II NSTEMI 2/2 PE.  PE was classified as unprovoked as she has no definite risk factors for this: no prior DVT/PE, no family history of clotting disorder, no evidence of malignancy (UTD with cancer screenings and visits PCP q6m for health maintenance), no cell line abnormalities, no prolonged immobility or long trips or surgeries, no trauma, no hormone or steroid therapies or even antidepressants. She is obese, and has mild CKD. She tested negative for COVID-19 by antigen testing. The only identifiable change in her health habits recently was receiving the first COVID-vaccine dose on 3/18. We discharged her with Eliquis with instructions to taper from 10BID to 5BID after 7 days. As she will be on anticoagulation, the benefit will likely outweigh the risk of receiving the second COVID dose.  She will follow up with her PCP and hematology/oncology.
very bad aches and pains; Hands were swollen; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 03Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset 04Feb2021, outcome "unknown", described as "very bad aches and pains"; PERIPHERAL SWELLING (non-serious) with onset 04Feb2021, outcome "unknown", described as "Hands were swollen".  Additional Information: The patient couldn't get out of bed because of the very bad aches and pains. The patient did not have the second scheduled but was wondering if she should get that second dose.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Injection site swollen(baseball size), warm and itchy. 8 days after injection.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  An 85-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Feb2021 at 08:00 as dose number unknown, single (Lot number: EL9265), in right arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Sulfa" (unspecified if ongoing); "known allergies: some adhesives" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient did not received other medication in 2 weeks. COVID 19 Treatment was given with Paxlovid.
This spontaneous report as received from a nurse via company representative refers to a 62 year old female patient. Patient concurrent and medical history was unspecified. On 30-OCT-2014 the patient was vaccinated with ZOSTAVAX (lot # J011333, expiry: 13-DEC-2014) (strength, route of administration, frequency and dose unknown). Concomitant medications were unspecified. On an unknown date in 2014 the patient experienced shingles post vaccination. Patient's husband (name unspecified) came in for a visit to the physician's office on unspecified date and mentioned that his wife came down with shingles despite receiving ZOSTAVAX. No additional information was provided. The outcome of event was unknown. Action taken was not applicable. Causality was unknown. No PQC was involved. Additional information has been requested.
Pt developed oval rash adjacent to site of vaccine. Believed there is not a causal relationship but informed parents would report.
experienced bloating; Gastrointestinal (GI) symptoms; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISTENSION (experienced bloating) and ABDOMINAL DISCOMFORT (Gastrointestinal (GI) symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISTENSION (experienced bloating) and ABDOMINAL DISCOMFORT (Gastrointestinal (GI) symptoms). At the time of the report, ABDOMINAL DISTENSION (experienced bloating) and ABDOMINAL DISCOMFORT (Gastrointestinal (GI) symptoms) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication product use was not provided by the reporter. No treatment information was provided.  Reporter was unsure if everything was related to the Moderna COVID-19 vaccine or other COVID-19 vaccines as well.   This case was linked to MOD-2021-287372 (E2B Linked Report). This case was linked to MOD-2021-287643 (Patient Link).; Sender's Comments:  MOD-2021-287372:same reporter
4 cm induration and inflammation on Right thigh 24 hours after given. Prescribed Cephalexin 125 mg every 10 hours for 7 days.
No additional AE; expired VAQTA that was administered; This spontaneous report has been received from an office manager concerning a 70 year old patient of unknown gender. The patient's medical history, drug allergies, concurrent conditions and concomitant therapies were not reported.   On 03-AUG-2020, the patient was vaccinated with an expired hepatitis a vaccine, inactivated (VAQTA) with lot # S007265 and expiration date 07-JUL-2020, for prophylaxis ((dose, dose number, route of administration and anatomical location were not provided). No adverse events were reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; manufactureraddress:; manufacturercity:; manufacturerstate:; manufacturercountry:; devicelotnumber: S007265; expirationdate: 07-JUL-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability